Treatment of Diabetic Foot Ulcers Addressed at Upcoming American Heart Assoc Meeting
13th Nov 2006, 16:40 GMT
Cardium Therapeutics and its subsidiary Tissue Repair Company announced that Dr Peter Sheehan of NY's Cabrini Med Cntr will review the therapeutic potential of Excellarate, a DNA-based collagen gel under development as a topical treatment of tissue wounds such as diabetic foot ulcers, at the American Heart Assoc Scientific Sessions 2006 in Chicago.
Treatment of Diabetic Foot Ulcers Addressed at Upcoming American Heart Assoc Meeting related news:
- New Data on Otsuka's Investigational Product for Hyponatremia Presented at American Heart Assoc Annual Meeting — Pharmaceuticals News from StratCenter.com
- Experts Call for Speedier Heart Care — WebMD Health Headlines
- Radiation Heart Dose From MammoSite Compared To IMRT For Left-Sided Breast Cancers — Health News from Medical News Today
- Diabetes Drug Shows Promise Against Heart Attacks — U.S. News & World Report
- Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease — ScienceDaily Headlines: Health & Medicine
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting — Partnerships/ Joint Ventures News from StratCenter.com
- NovaCardia Presents Phase II Data for KW-3902 at American Heart Assoc's 79th Annual Scientific Sessions — Nephrology/ Dialysis News from StratCenter.com
- Omron Healthcare's New Blood Pressure Monitor is the 1st to Measure Morning Hypertension — Intensive/ Critical Care News from StratCenter.com
- Study: arterial hardening begins in childhood — Health
- Late angioplasty after heart attack no better than drug therapy — EurekAlert! - Breaking News
Latest news from Nephrology/ Dialysis News from StratCenter.com:
- New Data Show ACTOS Halted Progression of Atherosclerosis as Indicated by CIMT in Patients with Type 2 Diabetes
- Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
- Aksys Reports Q3 2006 Financial Results
- Altus Pharmaceuticals Announces Presentation of ALTU-238 Phase II Data at Int'l Congress of Growth Hormone and Insulin-Like Growth Factor Research Societies
- Opexa Reports Q3 Financial Results
- Weight Loss Surgery Assists in Eliminating, Avoiding Type 2 Diabetes; American Institute of Gastric Banding Recognizes November as Nat'l Diabetes Month
- Federal Economic Development Agency Enlists Support of African-American Churches in the IL Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the MS Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the LA Delta
- Spherix Reports Q3 Earnings